Synergistic effects between silver nanoparticles and antibiotics and the mechanisms involved

References

1. Archer G. L. 1998; Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 26:1179–1181 [View Article][PubMed]
   [Google Scholar]
2. Atiyeh B. S., Costagliola M., Hayek S. N., Dibo S. A. 2007; Effect of silver on burn wound infection control and healing: review of the literature. Burns 33:139–148 [View Article][PubMed]
   [Google Scholar]
3. Christensen G. D., Simpson W. A., Younger J. J., Baddour L. M., Barrett F. F., Melton D. M., Beachey E. H. 1985; Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 22:996–1006[PubMed]
   [Google Scholar]
4. CLSI 2003 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved standard M7–A6 Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
5. CLSI 2005. Performance Standards for Antimicrobial Susceptibility Testing, Fifteenth Informational Supplement. Approved standard M100–S15 Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
6. Costerton J. W. 1999; Introduction to biofilm. Int J Antimicrob Agents 11:217–221, discussion 237–239 [View Article][PubMed]
   [Google Scholar]
7. Costerton J. W., Irvin R. T., Cheng K. J. 1981; The bacterial glycocalyx in nature and disease. Annu Rev Microbiol 35:299–324 [View Article][PubMed]
   [Google Scholar]
8. Eliopoulos G. M., Moellering R. C. 1991; Antimicrobial combinations. In Antibiotics in Laboratory Medicine, 3rd edn. pp. 432–492 Edited by Lorian V. Baltimore, MD: Williams & Wilkins;
   [Google Scholar]
9. Gonçalves P. P., Meireles S. M., Neves P., Vale M. G. 1999; Synaptic vesicle Ca²⁺/H⁺ antiport: dependence on the proton electrochemical gradient. Brain Res Mol Brain Res 71:178–184 [View Article][PubMed]
   [Google Scholar]
10. Gurunathan S., Lee K. J., Kalishwaralal K., Sheikpranbabu S., Vaidyanathan R., Eom S. H. 2009; Antiangiogenic properties of silver nanoparticles. Biomaterials 30:6341–6350 [View Article][PubMed]
    [Google Scholar]
11. Hojo K., Nagaoka S., Ohshima T., Maeda N. 2009; Bacterial interactions in dental biofilm development. J Dent Res 88:982–990 [View Article][PubMed]
    [Google Scholar]
12. Hwang I.-S., Lee J., Hwang J. H., Kim K.-J., Lee D. G. 2012; Silver nanoparticles induce apoptotic cell death in Candida albicans through the increase of hydroxyl radicals. FEBS J 279:1327–1338 [View Article][PubMed]
    [Google Scholar]
13. Jung H. J., Lee D. G. 2008; Synergistic antibacterial effect between silybin and N,N′-dicyclohexylcarbodiimide in clinical Pseudomonas aeruginosa isolates. J Microbiol 46:462–467 [View Article][PubMed]
    [Google Scholar]
14. Khardori N., Yassien M. 1995; Biofilms in device-related infections. J Ind Microbiol 15:141–147 [View Article][PubMed]
    [Google Scholar]
15. Kim K.-J., Sung W. S., Suh B. K., Moon S.-K., Choi J.-S., Kim J. G., Lee D. G. 2009; Antifungal activity and mode of action of silver nano-particles on Candida albicans . Biometals 22:235–242 [View Article][PubMed]
    [Google Scholar]
16. Kim J.-S., Heo P., Yang T.-J., Lee K.-S., Jin Y.-S., Kim S.-K., Shin D., Kweon D.-H. 2011; Bacterial persisters tolerate antibiotics by not producing hydroxyl radicals. Biochem Biophys Res Commun 413:105–110 [View Article][PubMed]
    [Google Scholar]
17. Klasen H. J. 2000; Historical review of the use of silver in the treatment of burns. I. Early uses. Burns 26:117–130 [View Article][PubMed]
    [Google Scholar]
18. Kohanski M. A., Dwyer D. J., Hayete B., Lawrence C. A., Collins J. J. 2007; A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797–810 [View Article][PubMed]
    [Google Scholar]
19. Lau G. W., Hassett D. J., Britigan B. E. 2005; Modulation of lung epithelial functions by Pseudomonas aeruginosa . Trends Microbiol 13:389–397 [View Article][PubMed]
    [Google Scholar]
20. Levy S. B. 1992; Active efflux mechanisms for antimicrobial resistance. Antimicrob Agents Chemother 36:695–703 [View Article][PubMed]
    [Google Scholar]
21. Li P., Li J., Wu C., Wu Q., Li J. 2005; Synergistic antibacterial effects of β-lactam antibiotic combined with silver nanoparticles. Nanotechnology 16:1912–1917 [View Article]
    [Google Scholar]
22. Linnett P. E., Beechey R. B. 1979; Inhibitors of the ATP synthetase systems. Methods Enzymol 55:472–518 [View Article][PubMed]
    [Google Scholar]
23. Lynch S. V., Dixon L., Benoit M. R., Brodie E. L., Keyhan M. P., Hu P., Ackerley D. F., Andersen G. L., Matin A. 2007; Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms. Antimicrob Agents Chemother 51:3650–3658 [CrossRef]
    [Google Scholar]
24. Monroe D. 2007; Looking for chinks in the armor of bacterial biofilms. PLoS Biol 5:e307 [View Article][PubMed]
    [Google Scholar]
25. Nadworny P. L., Wang J., Tredget E. E., Burrell R. E. 2008; Anti-inflammatory activity of nanocrystalline silver in a porcine contact dermatitis model. Nanomedicine 4:241–251 [View Article][PubMed]
    [Google Scholar]
26. Odds F. C. 2003; Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52:1 [View Article][PubMed]
    [Google Scholar]
27. Paju S., Scannapieco F. A. 2007; Oral biofilms, periodontitis, and pulmonary infections. Oral Dis 13:508–512 [View Article][PubMed]
    [Google Scholar]
28. Palmer J. 2006; Bacterial biofilms in chronic rhinosinusitis. Ann Otol Rhinol Laryngol Suppl 196:35–39[PubMed]
    [Google Scholar]
29. Pankey G. A., Ashcraft D. S. 2005; In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa . Antimicrob Agents Chemother 49:2959–2964 [View Article][PubMed]
    [Google Scholar]
30. Rogers J. V., Parkinson C. V., Choi Y. W., Speshock J. L., Hussain S. M. 2008; A preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque formation. Nanoscale Res Lett 3:129–133 [View Article]
    [Google Scholar]
31. Ruden S., Hilpert K., Berditsch M., Wadhwani P., Ulrich A. S. 2009; Synergistic interaction between silver nanoparticles and membrane-permeabilizing antimicrobial peptides. Antimicrob Agents Chemother 53:3538–3540 [View Article][PubMed]
    [Google Scholar]
32. Ruparelia J. P., Chatterjee A. K., Duttagupta S. P., Mukherji S. 2008; Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomater 4:707–716 [View Article][PubMed]
    [Google Scholar]
33. Shrivastava S., Bera T., Roy A., Singh G., Ramachandrarao P., Dash D. 2007; Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology 18:225103–225112 [View Article]
    [Google Scholar]
34. Sintubin L., De Windt W., Dick J., Mast J., van der Ha D., Verstraete W., Boon N. 2009; Lactic acid bacteria as reducing and capping agent for the fast and efficient production of silver nanoparticles. Appl Microbiol Biotechnol 84:741–749 [View Article][PubMed]
    [Google Scholar]
35. Swallow C. J., Grinstein S., Rotstein O. D. 1990; A vacuolar type H⁺-ATPase regulates cytoplasmic pH in murine macrophages. J Biol Chem 265:7645–7654[PubMed]
    [Google Scholar]
36. Venkatesh M., Rong L., Raad I., Versalovic J. 2009; Novel synergistic antibiofilm combinations for salvage of infected catheters. J Med Microbiol 58:936–944 [View Article][PubMed]
    [Google Scholar]
37. Wagner V. E., Iglewski B. H. 2008; P. aeruginosa biofilms in CF infection. Clin Rev Allergy Immunol 35:124–134 [View Article][PubMed]
    [Google Scholar]
38. Wei G. X., Campagna A. N., Bobek L. A. 2006; Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J Antimicrob Chemother 57:1100–1109 [View Article][PubMed]
    [Google Scholar]
39. Weisblum B., Davies J. 1968; Antibiotic inhibitors of the bacterial ribosome. Bacteriol Rev 32:493–528[PubMed]
    [Google Scholar]